Study 1 of 9Setmelanotide literatureThe New England journal of medicineTop journal2026
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.
Not reported in abstract.
Where it sits
this study against the rest of the setmelanotide corpus1
Preclinical · this one
6
Observational
0
Open-label
1
Randomised
1
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Setmelanotide corpus
BHuman HYPOMAP: A comprehensive spatio-cellular map of the human hypothalamusbiorxiv-preprint · 2023 · 182 neuronal clusters significantly enriched in expression of BMI GWAS genes.HumanBInversed impaired osteogenic activity in children with severe obesity due to MC4R deficiency compared to LEP and LEPR deficiencybiorxiv-preprint · 2025 · Serum osteocalcin and osteopontin levels were significantly lower in subjects with LEP and LEPR biallelic variants compared to controls, p<0.001.HumanASetmelanotide for the Treatment of Acquired Hypothalamic Obesity.The New England journal of medicine · 2023 · n=120 · LSM change in BMI at 52 weeks was -16.5% (95% CI, -19.3 to -13.8) with setmelanotide and 3.3% (95% CI, -0.6 to 7.2) with placebo (P<0.001)HumanARespiratory Adverse Events of Weight-Loss Drugs: A Systematic Review and Meta-Analysis.Annals of the American Thoracic Society · 2023 · n=123 · Nasopharyngitis incidence ranged from 4.1% (95% CI: 0.7%, 9.3%; tirzepatide, 0-6 months) to over 23.7% (95% CI: 19.6%, 28.1%; liraglutide, 13-24 months).HumanBDevelopmental Trajectories of Autistic Social Traits in Youth Born Extremely Preterm.Journal of the American Academy of Child and Adolescent Psychiatry · 2025 · n=527 · ASTs in EP youth increased an average of 19 raw points from age 10 to 17 years.HumanBRisk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor Agonists.Diabetes, obesity & metabolism · 2023 · n=68536 · RR: 0.45; 95% CI, 0.40-0.50 for cataract risk at 5 years.Human